2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Recurrent Childhood Central Nervous System Neoplasm: new trials by email Literature Review of Recurrent Childhood Central Nervous System Neoplasm trials Research Report on Recurrent Childhood Central Nervous System Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas Pharmacological Study, Selinexor - Malignant Glioma, Recurrent Brain Neoplasm | Phase 1 | Completed | Children's Oncology Group | 59 | 2015-10-30 | 2025-01-14 |
| Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies Laboratory Biomarker Analysis, Pharmacological Study, Talazoparib - Adult Solid Neoplasm, Childhood Solid Neoplasm | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 40 | 2014-05-16 | 2021-03-26 |
Central Nervous System Neoplasms (2) · Astrocytoma (1) · Brain Neoplasms (1) · Glioma (1) · Lymphoma (1) · Neuroectodermal Tumors, Primitive, Peripheral (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neoplasms, Neuroepithelial (2) · Nervous System Diseases (2) · Nervous System Neoplasms (2) · Neuroectodermal Tumors (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1)
Temozolomide (1) · selinexor (1) · talazoparib (1)
Children's Oncology Group (1) · National Cancer Institute (NCI) (1)
United States (2)
Eric S Schafer (1) · Julia Glade-Bender (1)
UM1CA097452 (2)